Terms: = Leukemia AND CDKN2C, P42773, 1031, ENSG00000123080, INK4C, p18, p18-INK4C
119 results:
1. All-Cause and Cause-Specific Mortality Among Low-Risk Differentiated Thyroid Cancer Survivors in the United States.
Tran TV; Schonfeld SJ; Pasqual E; Haymart MR; Morton LM; Kitahara CM
Thyroid; 2024 Feb; 34(2):215-224. PubMed ID: 38149602
[No Abstract] [Full Text] [Related]
2. Establishment and validation of a carbohydrate metabolism-related gene signature for prognostic model and immune response in acute myeloid leukemia.
Yang Y; Yang Y; Liu J; Zeng Y; Guo Q; Guo J; Guo L; Lu H; Liu W
Front Immunol; 2022; 13():1038570. PubMed ID: 36544784
[TBL] [Abstract] [Full Text] [Related]
3. Germline CHEK2 and ATM Variants in Myeloid and Other Hematopoietic Malignancies.
Stubbins RJ; Korotev S; Godley LA
Curr Hematol Malig Rep; 2022 Aug; 17(4):94-104. PubMed ID: 35674998
[TBL] [Abstract] [Full Text] [Related]
4.
Kayabasi C; Yilmaz Susluer S; Balci Okcanoglu T; Ozmen Yelken B; Mutlu Z; Goker Bagca B; Caliskan Kurt C; Saydam G; Durmuskahya C; Kayalar H; Ozbilgin A; Biray Avci C; Gunduz C
Nutr Cancer; 2022; 74(10):3679-3691. PubMed ID: 35608652
[No Abstract] [Full Text] [Related]
5. Classic myeloproliferative neoplasms in Singapore: A population-based study on incidence, trends, and survival from 1968 to 2017.
Htun HL; Lian W; Wong J; Tan EJ; Foo LL; Ong KH; Lim WY
Cancer Epidemiol; 2022 Aug; 79():102175. PubMed ID: 35569302
[TBL] [Abstract] [Full Text] [Related]
6. Patient-Derived In Vitro and In Vivo Models of Cancer.
Claridge SE; Cavallo JA; Hopkins BD
Adv Exp Med Biol; 2022; 1361():215-233. PubMed ID: 35230691
[TBL] [Abstract] [Full Text] [Related]
7. Rapid and non-invasive discrimination of acute leukemia bone marrow supernatants by Raman spectroscopy and multivariate statistical analysis.
Liang H; Cheng X; Dong S; Wang H; Liu E; Ru Y; Li Y; Kong X; Gao Y
J Pharm Biomed Anal; 2022 Feb; 210():114560. PubMed ID: 34999436
[TBL] [Abstract] [Full Text] [Related]
8. Overcoming of Microenvironment Protection on Primary Chronic Lymphocytic leukemia Cells after Treatment with BTK and MDM2 Pharmacological Inhibitors.
Rimondi E; Melloni E; Romani A; Tisato V; Casciano F; Rigolin GM; Milani D; Celeghini C; Zauli G; Secchiero P; Voltan R
Curr Oncol; 2021 Jul; 28(4):2439-2451. PubMed ID: 34287267
[TBL] [Abstract] [Full Text] [Related]
9. Vedolizumab for Steroid Refractory Lower Gastrointestinal Tract Graft-Versus-Host Disease.
Mehta RS; Saliba RM; Jan A; Shigle TL; Wang E; Nieto Y; Ciurea SO; Oran B; Im J; Olson A; Marin D; Qazilbash M; Khouri I; Rondon G; Anderlini P; Rezvani K; Popat U; Kebriaei P; Shpall E; Champlin R; Alousi A
Transplant Cell Ther; 2021 Mar; 27(3):272.e1-272.e5. PubMed ID: 33781539
[TBL] [Abstract] [Full Text] [Related]
10. Axolotl
Suleiman S; Di Fiore R; Cassar A; Formosa MM; Schembri-Wismayer P; Calleja-Agius J
Tumour Biol; 2020 Sep; 42(9):1010428320954735. PubMed ID: 32873193
[TBL] [Abstract] [Full Text] [Related]
11. Anticancer effects of an extract from a local planarian species on human acute myeloid leukemia HL-60 cells in vitro.
Suleiman S; Di Fiore R; Cassar A; Formosa MM; Calleja-Agius J; Schembri-Wismayer P
Biomed Pharmacother; 2020 Oct; 130():110549. PubMed ID: 32726743
[TBL] [Abstract] [Full Text] [Related]
12. Combined inhibition of menin-MLL interaction and TGF-β signaling induces replication of human pancreatic beta cells.
Pahlavanneshan S; Behmanesh M; Oropeza D; Furuyama K; Tahamtani Y; Basiri M; Herrera PL; Baharvand H
Eur J Cell Biol; 2020 Jun; 99(5):151094. PubMed ID: 32646642
[TBL] [Abstract] [Full Text] [Related]
13. Frequent Mutations of POT1 Distinguish Pulmonary Sarcomatoid Carcinoma From Other Lung Cancer Histologies.
Shen E; Xiu J; Bentley R; López GY; Walsh KM
Clin Lung Cancer; 2020 Nov; 21(6):e523-e527. PubMed ID: 32414627
[TBL] [Abstract] [Full Text] [Related]
14. Hematopoietic cell transplantation utilization and outcomes for primary plasma cell leukemia in the current era.
Dhakal B; Patel S; Girnius S; Bachegowda L; Fraser R; Davila O; Kanate AS; Assal A; Hanbali A; Bashey A; Pawarode A; Freytes CO; Lee C; Vesole D; Cornell RF; Hildebrandt GC; Murthy HS; Lazarus HM; Cerny J; Yared JA; Schriber J; Berdeja J; Stockerl-Goldstein K; Meehan K; Holmberg L; Solh M; Diaz MA; Kharfan-Dabaja MA; Farhadfar N; Bashir Q; Munker R; Olsson RF; Gale RP; Bayer RL; Seo S; Chhabra S; Hashmi S; Badawy SM; Nishihori T; Gonsalves W; Nieto Y; Efebera Y; Kumar S; Shah N; Qazilbash M; Hari P; D'Souza A
Leukemia; 2020 Dec; 34(12):3338-3347. PubMed ID: 32313109
[TBL] [Abstract] [Full Text] [Related]
15. [Safety and efficacy of patients with refractory B-lymphoblastic leukemia treated with anti-CD19 CAR-T cell bridging to allogeneic hematopoietic stem cell transplantation].
Ai H; Yin QS; Wang Q; Fu YW; Wei XD; Song YP
Zhonghua Xue Ye Xue Za Zhi; 2020 Mar; 41(3):239-244. PubMed ID: 32311895
[No Abstract] [Full Text] [Related]
16. [Expression and Significance of BTLA and Its Ligand HVEM in Patients with Chronic Myelomonocytic leukemia].
Li C; Geng SX; Li MM; Su F; Chen XM; Deng CX; Huang X; Lai PL; Weng JY; DU X
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Feb; 28(1):56-62. PubMed ID: 32027253
[TBL] [Abstract] [Full Text] [Related]
17. Novel Pyrazolo[3,4-d]pyrimidines as Potential Cytotoxic Agents: Design, Synthesis, Molecular Docking and CDK2 Inhibition.
Maher M; Kassab AE; Zaher AF; Mahmoud Z
Anticancer Agents Med Chem; 2019; 19(11):1368-1381. PubMed ID: 31038080
[TBL] [Abstract] [Full Text] [Related]
18. The potential health gain and cost savings of improving adherence in chronic myeloid leukemia.
Ector GICG; Govers TM; Westerweel PE; Grutters JPC; Blijlevens NMA
Leuk Lymphoma; 2019 Jun; 60(6):1485-1492. PubMed ID: 30668187
[TBL] [Abstract] [Full Text] [Related]
19. HDAC inhibitor suppresses proliferation and tumorigenicity of drug-resistant chronic myeloid leukemia stem cells through regulation of hsa-miR-196a targeting BCR/ABL1.
Bamodu OA; Kuo KT; Yuan LP; Cheng WH; Lee WH; Ho YS; Chao TY; Yeh CT
Exp Cell Res; 2018 Sep; 370(2):519-530. PubMed ID: 30017934
[TBL] [Abstract] [Full Text] [Related]
20. SETDB2 Links E2A-PBX1 to Cell-Cycle Dysregulation in Acute leukemia through cdkn2c Repression.
Lin CH; Wong SH; Kurzer JH; Schneidawind C; Wei MC; Duque-Afonso J; Jeong J; Feng X; Cleary ML
Cell Rep; 2018 Apr; 23(4):1166-1177. PubMed ID: 29694893
[TBL] [Abstract] [Full Text] [Related]
[Next]
